Challenges and Opportunities of Defining Clinical Leptin Resistance
Martin G. Myers(University of Michigan), Jack A. Yanovski(National Institutes of Health), Maren R. Laughlin(National Institutes of Health), Rudolph L. Leibel(Columbia University), Matthias H. Tschöp(Helmholtz Zentrum München), Barbara B. Kahn(Beth Israel Deaconess Medical Center), Carol Renfrew Haft(National Institute of Diabetes and Digestive and Kidney Diseases), Steven B. Heymsfield(Pennington Biomedical Research Center)
Cited by 237
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Obesity and insulin resistance
|Journal of Clinical Investigation|2000|3.2k
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
|Cell Metabolism|2005|2.8k